Orchestra BioMed Holdings, Inc. - Ordinary Shares —— 现金流量表 (NASDAQ:OBIO) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 —-272.36 K-1.58 M-46.13 M-50.56 M-48.96 M -54.52 M 投资活动产生的现金 —092.59 M10.69 M13.09 M-26.94 M -29.62 M 融资活动产生的现金 —0-92.59 M46.22 M29.17 M88.33 M 94.16 M 自由现金流 —-272.36 K-1.58 M-46.13 M-50.56 M-49.45 M -55.08 M

新闻

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates

Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates

Chardan重申Orchestra BioMed股票评级,聚焦临床试验进展

Chardan reiterates Orchestra BioMed stock rating on trial focus

Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates

Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates

Orchestra BioMed to present hypertension therapy data at medical meetings

TD Cowen 以新型医疗设备组合为由，给予 Orchestra BioMed 股票买入评级

TD Cowen initiates Orchestra BioMed stock with Buy rating on novel medical device portfolio

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates